AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

Data as of 2:38pm ET
 -0.07 / -1.05%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company that focuses on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. Its lead product candidate, the ARX-01 Sufentanil NanoTab(TM) PCA System, which has completed Phase 2 clinical development, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia (IV PCA) which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the inherent potential for programming and delivery errors associated with the complexity of infusion pumps. The company's other products include; ARX-02 for the treatment of cancer breakthrough pain, ARX-03 for providing mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office and ARX-04, designed to provide a non-invasive, fast-onset treatment of moderate-to-severe acute pain in patients with trauma or injury. AcelRx Pharmaceuticals was founded by Thomas A. Schreck and Pamela P. Palmer on July 13, 2005 and is headquartered in Redwood City, CA.

Contact Information

AcelRx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City California 94063
P:(650) 216-3500
Investor Relations:



Individual stakeholders30.01%
Other institutional28.83%
Mutual fund holders18.73%

Top Executives

Richard A. KingPresident, Chief Executive Officer & Director
Timothy E. MorrisChief Financial Officer
Pamela Pierce PalmerDirector & Chief Medical Officer
Mark A. EvashenkVice President-Clinical Operations
Lawrence G. HamelChief Development Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.